- Home
- Publications
- Publication Search
- Publication Details
Title
Tumor vasculature: the Achilles' heel of cancer?
Authors
Keywords
-
Journal
EXPERT OPINION ON THERAPEUTIC TARGETS
Volume 17, Issue 1, Pages 7-20
Publisher
Informa Healthcare
Online
2012-11-02
DOI
10.1517/14728222.2013.730522
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bevacizumab (BEV) plus chemotherapy (CT) continued beyond first progression in patients with metastatic colorectal cancer (mCRC) previously treated with BEV plus CT: Results of a randomized phase III intergroup study (TML study).
- (2017) Dirk Arnold et al. JOURNAL OF CLINICAL ONCOLOGY
- Neoplastic cells are a rare component in human glioblastoma microvasculature
- (2015) Fausto J. Rodriguez et al. Oncotarget
- Pericyte Depletion Results in Hypoxia-Associated Epithelial-to-Mesenchymal Transition and Metastasis Mediated by Met Signaling Pathway
- (2012) Vesselina G. Cooke et al. CANCER CELL
- VEGF Inhibits Tumor Cell Invasion and Mesenchymal Transition through a MET/VEGFR2 Complex
- (2012) Kan V. Lu et al. CANCER CELL
- HGF/c-Met pathway is one of the mediators of sunitinib-induced tumor cell type-dependent metastasis
- (2012) Farbod Shojaei et al. CANCER LETTERS
- Molecular Pathways: Vasculogenic Mimicry in Tumor Cells: Diagnostic and Therapeutic Implications
- (2012) D. A. Kirschmann et al. CLINICAL CANCER RESEARCH
- miR-221 Is Required for Endothelial Tip Cell Behaviors during Vascular Development
- (2012) Stefania Nicoli et al. DEVELOPMENTAL CELL
- VEGF pathway genetic variants as biomarkers of treatment outcome with bevacizumab: an analysis of data from the AViTA and AVOREN randomised trials
- (2012) Diether Lambrechts et al. LANCET ONCOLOGY
- Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET
- (2012) Héctor Peinado et al. NATURE MEDICINE
- Clinical Efficacy and Safety of Bevacizumab Monotherapy in Patients with Metastatic Melanoma: Predictive Importance of Induced Early Hypertension
- (2012) Cornelia Schuster et al. PLoS One
- Autophagy Suppresses RIP Kinase-Dependent Necrosis Enabling Survival to mTOR Inhibition
- (2012) Kevin Bray et al. PLoS One
- Suppression of heat shock protein 27 induces long-term dormancy in human breast cancer
- (2012) O. Straume et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tumor kinase activity in locally advanced rectal cancer: angiogenic signaling and early systemic dissemination
- (2011) Marie Grøn Saelen et al. ANGIOGENESIS
- miR-27b controls venous specification and tip cell fate
- (2011) D. Biyashev et al. BLOOD
- Receptor Tyrosine Kinases and TLR/IL1Rs Unexpectedly Activate Myeloid Cell PI3Kγ, A Single Convergent Point Promoting Tumor Inflammation and Progression
- (2011) Michael C. Schmid et al. CANCER CELL
- Targeting the ANG2/TIE2 Axis Inhibits Tumor Growth and Metastasis by Impairing Angiogenesis and Disabling Rebounds of Proangiogenic Myeloid Cells
- (2011) Roberta Mazzieri et al. CANCER CELL
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Brivanib, a Dual FGF/VEGF Inhibitor, Is Active Both First and Second Line against Mouse Pancreatic Neuroendocrine Tumors Developing Adaptive/Evasive Resistance to VEGF Inhibition
- (2011) Elizabeth Allen et al. CLINICAL CANCER RESEARCH
- Key predictive factors of axitinib (AG-013736)-induced proteinuria and efficacy: A phase II study in Japanese patients with cytokine-refractory metastatic renal cell Carcinoma
- (2011) Yoshihiko Tomita et al. EUROPEAN JOURNAL OF CANCER
- The role of pericytes in angiogenesis
- (2011) Domenico Ribatti et al. INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY
- Biomarkers in Tumor Angiogenesis and Anti-Angiogenic Therapy
- (2011) Andreas Pircher et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Targeting the Angiopoietin/Tie2 Pathway: Cutting Tumor Vessels With a Double-Edged Sword?
- (2011) Tina Cascone et al. JOURNAL OF CLINICAL ONCOLOGY
- Hypertension as a Biomarker of Efficacy in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib
- (2011) B. I. Rini et al. JNCI-Journal of the National Cancer Institute
- VEGFR-3 controls tip to stalk conversion at vessel fusion sites by reinforcing Notch signalling
- (2011) Tuomas Tammela et al. NATURE CELL BIOLOGY
- PDGF-BB modulates hematopoiesis and tumor angiogenesis by inducing erythropoietin production in stromal cells
- (2011) Yuan Xue et al. NATURE MEDICINE
- Tumor angiogenesis: molecular pathways and therapeutic targets
- (2011) Sara M Weis et al. NATURE MEDICINE
- Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases
- (2011) Peter Carmeliet et al. NATURE REVIEWS DRUG DISCOVERY
- Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer
- (2011) José Baselga et al. NEW ENGLAND JOURNAL OF MEDICINE
- A New Method for Isolation of Interstitial Fluid from Human Solid Tumors Applied to Proteomic Analysis of Ovarian Carcinoma Tissue
- (2011) Hanne Haslene-Hox et al. PLoS One
- Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma
- (2011) Olivier Keunen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tissue macrophages act as cellular chaperones for vascular anastomosis downstream of VEGF-mediated endothelial tip cell induction
- (2010) A. Fantin et al. BLOOD
- Clinical Course of Advanced Non–Small-Cell Lung Cancer Patients Experiencing Hypertension During Treatment With Bevacizumab in Combination With Carboplatin and Paclitaxel on ECOG 4599
- (2010) Suzanne E. Dahlberg et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I/IIa Study of Cilengitide and Temozolomide With Concomitant Radiotherapy Followed by Cilengitide and Temozolomide Maintenance Therapy in Patients With Newly Diagnosed Glioblastoma
- (2010) Roger Stupp et al. JOURNAL OF CLINICAL ONCOLOGY
- Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells
- (2010) Lucia Ricci-Vitiani et al. NATURE
- Glioblastoma stem-like cells give rise to tumour endothelium
- (2010) Rong Wang et al. NATURE
- Plasma Soluble VEGFR-1 Is a Potential Dual Biomarker of Response and Toxicity for Bevacizumab with Chemoradiation in Locally Advanced Rectal Cancer
- (2010) D. G. Duda et al. ONCOLOGIST
- Heterogeneity of the Tumor Vasculature
- (2010) Janice Nagy et al. SEMINARS IN THROMBOSIS AND HEMOSTASIS
- Cross-talk between the VEGF-A and HGF signalling pathways in endothelial cells
- (2009) Eric Sulpice et al. BIOLOGY OF THE CELL
- Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis
- (2009) Marta Pàez-Ribes et al. CANCER CELL
- Novel Therapeutic Inhibitors of the c-Met Signaling Pathway in Cancer
- (2009) J. P. Eder et al. CLINICAL CANCER RESEARCH
- An integrin αvβ3–c-Src oncogenic unit promotes anchorage-independence and tumor progression
- (2009) Jay S Desgrosellier et al. NATURE MEDICINE
- Antiangiogenic therapies for high-grade glioma
- (2009) Andrew D. Norden et al. Nature Reviews Neurology
- Combined Anti-Angiogenic Therapy Targeting PDGF and VEGF Receptors Lowers the Interstitial Fluid Pressure in a Murine Experimental Carcinoma
- (2009) Agnieszka Kłosowska-Wardęga et al. PLoS One
- Drug resistance associated with antiangiogenesis therapy
- (2009) Hans Petter Eikesdal et al. SEMINARS IN CANCER BIOLOGY
- Stem-Like Ovarian Cancer Cells Can Serve as Tumor Vascular Progenitors
- (2009) Ayesha B. Alvero et al. STEM CELLS
- Arterial hypertension correlates with clinical outcome in colorectal cancer patients treated with first-line bevacizumab
- (2008) M. Scartozzi et al. ANNALS OF ONCOLOGY
- PGE2 induces angiogenesis via MT1-MMP-mediated activation of the TGF /Alk5 signaling pathway
- (2008) A. Alfranca et al. BLOOD
- Expression of Integrin αvβ3in Gliomas Correlates with Tumor Grade and Is not Restricted to Tumor Vasculature
- (2008) Oliver Schnell et al. BRAIN PATHOLOGY
- Tumor Escape from Endogenous, Extracellular Matrix-Associated Angiogenesis Inhibitors by Up-Regulation of Multiple Proangiogenic Factors
- (2008) N. T. Fernando et al. CLINICAL CANCER RESEARCH
- Axitinib for renal cell carcinoma
- (2008) Guru Sonpavde et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Identification of a tumor-initiating stem cell population in human renal carcinomas
- (2008) Benedetta Bussolati et al. FASEB JOURNAL
- Tumor microenvironment and angiogenesis
- (2008) Pia Nyberg Frontiers in Bioscience-Landmark
- Endothelial cell differentiation of human breast tumour stem/progenitor cells
- (2008) Benedetta Bussolati et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Association of Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor-2 Genetic Polymorphisms With Outcome in a Trial of Paclitaxel Compared With Paclitaxel Plus Bevacizumab in Advanced Breast Cancer: ECOG 2100
- (2008) Bryan P. Schneider et al. JOURNAL OF CLINICAL ONCOLOGY
- R Regulation of tumor angiogenesis and metastasis by FGF and PDGF signaling pathways
- (2008) Yihai Cao et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Targeting EGFR activity in blood vessels is sufficient to inhibit tumor growth and is accompanied by an increase in VEGFR-2 dependence in tumor endothelial cells
- (2008) Dhara N. Amin et al. MICROVASCULAR RESEARCH
- Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation
- (2008) Tuomas Tammela et al. NATURE
- Tumor Angiogenesis
- (2008) Robert S. Kerbel NEW ENGLAND JOURNAL OF MEDICINE
- Precancerous Stem Cells Can Serve As Tumor Vasculogenic Progenitors
- (2008) Rulong Shen et al. PLoS One
- Identification of amino acids essential for the antiangiogenic activity of tumstatin and its use in combination antitumor activity
- (2008) H. P. Eikesdal et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth
- (2008) S. Purhonen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started